Dr. Daniel Elbogdadi, MD
- Medicare services, 2024
- 85,079
- Medicare patients, 2024
- 805
- Part D claims, 2024
- 1,247
- MIPS score, 2024
- 86
- Industry payments
- $53,713
- Practice address
- 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031
- Practice phone
- Call (301) 942-7600
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Arthritis and Rheumatism Associates
Fairfax, Virginia
Find Dr. Elbogdadi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel Elbogdadi is a rheumatologist in Fairfax, Virginia
Dr. Elbogdadi practices at Arthritis and Rheumatism Associates in Fairfax, Virginia.
Dr. Elbogdadi's NPI, 1528186285, was assigned on March 27, 2007. Dr. Elbogdadi graduated from George Washington University School of Medicine and Health Sciences in 2001. Dr. Elbogdadi holds Maryland license D0077404.
- NPI
- 1528186285NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6103891569
- NPI enumeration date
- March 27, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (301) 942-7600
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 51
- Medical school graduation
- 2001
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel Elbogdadi practices at Arthritis and Rheumatism Associates in Fairfax, Virginia
Dr. Elbogdadi's primary practice is Arthritis and Rheumatism Associates, at 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031 in Fairfax County. The practice phone is (301) 942-7600.
- Arthritis and Rheumatism Associates8270 Willow Oaks Corporate Dr, Fairfax, VA 22031 · Fairfax CountyPhone(301) 942-7600
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Daniel Elbogdadi is affiliated with 2 sites of care and 1 medical group
Dr. Elbogdadi's primary practice is Arthritis and Rheumatism Associates in Fairfax, Virginia. The medical group on file is Arthritis and Rheumatism Associates, P.C. Dmand AI also links Dr. Elbogdadi to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Daniel Elbogdadi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elbogdadi practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Arthritis and Rheumatism Associates | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel Elbogdadi is one of 160 rheumatologists in Virginia
Rheumatology is Dr. Elbogdadi's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Elbogdadi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Elbogdadi's licenses on file in 4 states: Maryland, Virginia, District of Columbia and Georgia.
Specialties and state licenses
- Rheumatology, MarylandPrimary
- Virginia license
- District of Columbia license
- Georgia license
Clinical focus
Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Elbogdadi treats.
Rheumatologists near Dr. Elbogdadi
Counts of rheumatologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel Elbogdadi billed Medicare for 85,079 services in 2024
CMS data shows 85,079 Medicare services from Dr. Elbogdadi across 64 procedure codes in 2024, for 805 Medicare patients. Medicare paid $913,657 for them. Every service was in an office.
Dr. Elbogdadi's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 68,5772024: 77,37913%
- Lab and pathology
- 2023: 3,6022024: 3,18612%
- Office and hospital visits
- 2023: 1,3542024: 1,2279%
- Tests and treatments
- 2023: 7182024: 1,12657%
- Other services
- 2023: 02024: 1,075
- Surgery
- 2023: 8072024: 61024%
- Imaging
- 2023: 5092024: 4766%
Dr. Elbogdadi compared with the Virginia median for rheumatologists, 2024
- Dr. Elbogdadi
- Virginia median
- Medicare services
- 85,079vs 99985.2 times
- Medicare patients
- 805vs 3042.6 times
- Part D claims
- 1,040vs 9707% above
Medians across 159 rheumatologists in Virginia with Dmand AI profiles that report each measure.
Dr. Elbogdadi's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Elbogdadi?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Elbogdadi and other rheumatologists in Virginia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daniel Elbogdadi treated 805 Medicare patients in 2024, average age 75
CMS counts 805 Medicare patients who saw Dr. Elbogdadi in 2024. The largest group is 65 to 74, with 356 patients. 75% of them have arthritis, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Elbogdadi's median patient age at 62, with 75% women.
Dr. Elbogdadi's Medicare patients by age, 2024
Dr. Elbogdadi's Medicare patients by sex, 2024
- Women63379%
- Men17221%
Chronic conditions among Dr. Elbogdadi's Medicare patients, 2024
- Arthritis75%
- High cholesterol75%
- High blood pressure66%
- Osteoporosis54%
- Ischemic heart disease26%
- Mood disorders24%
- Diabetes23%
- Anxiety22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Elbogdadi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 62
Patient panel by sex, all payers
- Women75%
- Men24%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Daniel Elbogdadi wrote 1,247 Medicare Part D claims in 2024
In 2024, Dr. Elbogdadi wrote 1,247 Medicare Part D claims for 233 patients. 90% of them were for generic drugs. CMS names the drug for 1,040 of them, across 23 drugs with 11 or more claims each, at $690,419 in total drug cost. In 2023, CMS named 1,007 claims across 23 drugs.
Dr. Elbogdadi's Part D claims by kind of drug, 2024
- Generic1,124 claims90%
- Brand-name and other123 claims10%
Dr. Elbogdadi's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Elbogdadi's Part D claims, 2024
- Opioids6%78 of 1,247 claims
- Antibiotics1%11 of 1,247 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0072024: 1,0403%
Drugs named by CMS: 23 in 2024, 23 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Daniel Elbogdadi scored 86 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Elbogdadi for performance year 2024, reported as part of a group. Dr. Elbogdadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elbogdadi as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Elbogdadi's MIPS scores, performance year 2024
- 86of 100Final score
- 93.4of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 59of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daniel Elbogdadi received $53,713 in industry payments from 2016 to 2025
CMS Open Payments shows 490 general payments to Dr. Elbogdadi from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 39% of the total. Abbvie Inc. paid the most, $26,581.
General payments to Dr. Elbogdadi by program year, 2016 to 2025
General payments to Dr. Elbogdadi by kind, 2016 to 2025
- Speaker and faculty fees$21,15039%
- Food and beverage$10,99420%
- Consulting fees$9,28017%
- Honoraria$8,10015%
- Other$4,1898%
Companies that paid Dr. Elbogdadi the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Daniel Elbogdadi has 1 award and honors on record
Dmand AI lists 1 award for Dr. Elbogdadi, most recently CMS Stage 1 EHR in 2012.
Awards and honors for Dr. Elbogdadi
- 2012
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Daniel Elbogdadi graduated from George Washington University School of Medicine and Health Sciences
Dr. Elbogdadi graduated from George Washington University School of Medicine and Health Sciences in 2001.
- Medical school
- Board certified in internal medicine
- Board certified in rheumatology
Source: Dmand AI Professional Profile Data
Dr. Daniel Elbogdadi accepts plans from 7 insurance carriers
Dr. Elbogdadi is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.
- Aetna
- Blue Cross Blue Shield of Michigan
- United Healthcare
- CareFirst BlueCross BlueShield
- Blue Cross and Blue Shield of Kansas City
- CMS Medicare
- WV State Medicaid
Plan types Dr. Elbogdadi accepts, by number of carriers
- HMO4
- Medicare3
- POS3
- PPO3
- EPO2
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Daniel Elbogdadi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel Elbogdadi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel Elbogdadi's NPI number?
Dr. Daniel Elbogdadi's NPI number is 1528186285. It was assigned on March 27, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel Elbogdadi?
Dr. Daniel Elbogdadi is a rheumatologist in Fairfax, Virginia. The primary specialty in the NPI Registry is Rheumatology Physician (taxonomy code 207RR0500X).
Where does Dr. Daniel Elbogdadi practice?
Dr. Elbogdadi practices at 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031. Dr. Elbogdadi's primary practice is Arthritis and Rheumatism Associates in Fairfax, Virginia. Dmand AI also links Dr. Elbogdadi to 1 group practice or clinic.
What is Dr. Daniel Elbogdadi's office phone number?
The practice phone on file for Dr. Elbogdadi is (301) 942-7600.
What is Dr. Daniel Elbogdadi's medical license number?
Dr. Elbogdadi holds Maryland license D0077404, one of the licenses on file in 4 states.
Which states has Dr. Daniel Elbogdadi been licensed in?
Dmand AI has state licenses on file for Dr. Elbogdadi in Maryland (2014 to 2026), Virginia (2007 to 2026), District of Columbia (2014 to 2016) and Georgia (2003 to 2007).
What medical group is Dr. Daniel Elbogdadi part of?
Dr. Elbogdadi is linked to Arthritis and Rheumatism Associates, P.C.
Does Dr. Daniel Elbogdadi accept Medicare?
Yes. CMS data shows Dr. Elbogdadi billed Medicare for 85,079 services in 2024, and Dr. Elbogdadi accepts Medicare assignment.
Does Dr. Daniel Elbogdadi offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Elbogdadi as offering telehealth services.
What is Dr. Daniel Elbogdadi's MIPS score?
Dr. Elbogdadi's MIPS final score for performance year 2024 is 86 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Daniel Elbogdadi see?
CMS counts 805 Medicare patients who saw Dr. Elbogdadi in 2024, with an average age of 75.
Is Dr. Daniel Elbogdadi board certified?
Yes. Dr. Elbogdadi is board certified in internal medicine by the American Board of Internal Medicine.
What services does Dr. Daniel Elbogdadi bill to Medicare?
In 2024, Dr. Elbogdadi's most billed Medicare services were injected or infused drug (J3262), injected or infused drug (J3111) and injected or infused drug (J0897).
Where did Dr. Daniel Elbogdadi go to medical school?
Dr. Elbogdadi graduated from George Washington University School of Medicine and Health Sciences in 2001.
What drugs does Dr. Daniel Elbogdadi prescribe most?
In 2024 Medicare Part D data, Dr. Elbogdadi's most prescribed drugs by claims were Prednisone, Hydroxychloroquine Sulfate and Methotrexate.
Has Dr. Daniel Elbogdadi received payments from drug or device companies?
CMS Open Payments shows $53,713 in general payments to Dr. Elbogdadi from 35 companies from 2016 to 2025. The largest total came from Abbvie Inc.
How long has Dr. Daniel Elbogdadi been practicing?
Dr. Elbogdadi graduated from medical school in 2001, 25 years ago.
What insurance does Dr. Daniel Elbogdadi accept?
Dr. Elbogdadi is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.
Selling to rheumatology practices?
See rheumatologists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card